Home/Recalls/CANADA-23003
Health CanadaGeneral Alert

Archived - New restrictions on the use of rosiglitazone products due to cardiac ...

Published: November 6, 2007Recall ID: 23003Category: generalCountry: Canada

Product Description & Identification

Archived - New restrictions on the use of rosiglitazone products due to cardiac safety concerns (AVANDIA, AVANDAMET and AVANDARYL) - For the Public

Additional Source Details

FieldValue
N I D23003
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/archived-new-restrictions-use-rosiglitazone-products-due-cardiac-safety-concerns
Title Archived - New restrictions on the use of rosiglitazone products due to cardiac safety concerns (AVANDIA, AVANDAMET and AVANDARYL) - For the Public
Archived1
CategoryDrugs
Last updated2007-11-06
OrganizationMarketed health products

Overview

  • Recalling FirmMarketed health products
Official Agency Alert